GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moderna Inc (BSP:M1RN34) » Definitions » Capital Expenditure

Moderna (BSP:M1RN34) Capital Expenditure : R$-3,870.48 Mil (TTM As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Moderna Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Moderna's cash flow for capital expenditures for the three months ended in Sep. 2024 was R$-836 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Sep. 2024 was R$-3,870.48 Mil.

Moderna Capital Expenditure Historical Data

The historical data trend for Moderna's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moderna Capital Expenditure Chart

Moderna Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capital Expenditure
Get a 7-Day Free Trial -131.34 -349.84 -1,605.99 -2,098.16 -3,464.16

Moderna Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -691.42 -1,077.96 -976.04 -980.27 -836.21

Moderna Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$-3,870.48 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Moderna Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moderna Inc (BSP:M1RN34) » Definitions » Capital Expenditure
Comparable Companies
BNTX BGNE ALNY SGEN BMRN RPRX LEGN INCY UTHR SRPT OCSE:NOVO B VRTX REGN ASX:CSL XKRX:207940 HKSE:02269 XBRU:ARGX SZSE:300122 OCSE:GMAB XKRX:068270
Traded in Other Exchanges
MRNA:USA MRNA:Peru MRNA:Mexico 1MRNA:Italy 0QFd:UK 0A45:UK 0QF:Germany MRNA:Austria
Address
200 Technology Square, Cambridge, MA, USA, 02139
Website
https://www.modernatx.com
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Moderna Headlines

No Headlines